OPKO HEALTH INC - NOTE 4.500% 2/1

Historical Holders from Q1 2019 to Q1 2024

Type / Class
Debt / NOTE 4.500% 2/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of OPKO HEALTH INC - NOTE 4.500% 2/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2024 Q1 $0 $0 -$128,130,286 0
2023 Q4 $144,410,000 $146,665,218 +$11,472,065 98.22% 6
2023 Q3 $118,671,750 $128,590,258 -$37,740 98.75% 6
2023 Q2 $132,711,750 $151,311,983 +$58,709 101.4% 6
2023 Q1 $118,711,750 $121,807,693 +$7,831,483 93.27% 5
2022 Q4 $127,958,000 $123,577,100 +$28,504,037 87.89% 6
2022 Q3 $98,840,000 $97,590,000 -$52,589,550 94.82% 5
2022 Q2 $141,165,000 $143,565,000 +$27,971,865 102.15% 6
2022 Q1 $113,465,000 $132,997,000 +$12,361,793 118.18% 6
2021 Q4 $100,265,000 $138,986,000 -$50,786,390 138.5% 8
2021 Q3 $144,040,000 $178,181,000 -$10,279,869 123.96% 13
2021 Q2 $157,955,287 $205,914,996 -$64,723,939 130.4% 14
2021 Q1 $196,376,287 $268,923,405 -$7,516,653 133.76% 14
2020 Q4 $200,490,000 $253,178,000 +$336,312 126.1% 13
2020 Q3 $204,577,000 $238,103,000 +$21,303,536 118.33% 13
2020 Q2 $183,417,908 $190,836,143 +$5,108,372 104.28% 14
2020 Q1 $187,721,000 $124,178,679 -$4,831,402 66.09% 14
2019 Q4 $191,560,000 $150,091,000 -$3,879,635 78.35% 14
2019 Q3 $196,385,000 $161,587,000 +$5,689,621 82.34% 15
2019 Q2 $188,889,500 $165,147,949 +$5,259,713 87.6% 18
2019 Q1 $181,053,800 $171,148,422 +$171,148,422 94.6% 22